Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)

China · Delayed Price · Currency is CNY

27.40

+0.62 (2.32%)

Aug 20, 2026, 3:00 PM CST

-15.12% (1Y)

Market Cap	3.71B -15.1%
Revenue (ttm)	1.34B +1.9%
Net Income	152.02M +2.4%
EPS	1.12 +2.8%
Shares Out	135.44M
PE Ratio	24.47
Forward PE	n/a
Dividend	0.60 (2.16%)
Ex-Dividend Date	Jun 5, 2026

Volume	1,757,080
Open	27.30
Previous Close	26.78
Day's Range	26.94 - 27.76
52-Week Range	21.90 - 32.60
Beta	0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 22, 2026

About SHA:603351

Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical excipients and synthetic lubricating base oils to the pharmaceutical companies in China and internationally. The company offers excipients for injection, oral, and topical applications; and active pharmaceutical ingredients (API), such as polidocanol and polyethylene glycol 3350 API/polyethylene glycol 4000 API. It also provides biomaterial products; water-ethylene glycol fire resistant hydraulic fluid, biodegradable hydrau... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2000

Employees 718

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603351

Full Company Profile

Financial Performance

In 2025, SHA:603351's revenue was 1.34 billion, an increase of 2.95% compared to the previous year's 1.30 billion. Earnings were 150.97 million, an increase of 3.11%.

Financial Statements